Administration of IL-12 induces a CD3+CD4-CD8-B220+ lymphoid population capable of eliciting cytolysis against fas-positive tumor cells

Journal of Immunology

Volumn 159, Issue 6, 1997, Pages 2599-2605

  Tsutsui, Tateki ^a   Mu, Jie ^a   Ogawa, Makoto ^a   Yu, Wen Gong ^a   Suda, Takashi ^b   Nagaga, Shigekazu ^a   Saji, Fumitaka ^a   Murata, Yuji ^a   Fujiwara, Hiromi ^a   Hamaoka, Toshiyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 12;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CYTOTOXICITY; EXPERIMENTAL NEOPLASM; HUMAN; IMMUNOLOGY; MALE; MOUSE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD8; ANTIGENS, CD95; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERLEUKIN-12; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED;

EID: 0031571742     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008.
2. Brunda, M. J. 1994. Interleukin-12. J. Leukocyte Biol. 55:280.
3. Kobayashi, M., L. Fitz, M. Ryan. R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
4. Stern, A. S., F. J. Podlaski, J. D. Hulmes, Y. C. Pan, P. M. Quinn, A. G. Wolitzky, P. C. Familletti, D. L. Stremlo, T. Truitt, R. Chizzonite, and M. K. Gately. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87:6808.
5. Robertson, M. J., R. J. Soiffer, S. F. Wolf, T. J. Manley, C. Donahue, D. Young, S. H. Herrmann, and J. Ritz. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175:779.
6. Gately, M. K., B. B. Desai, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, F. J. Podlaski, P. C. Familletti, F. Sinigaglia, R. Chizonnite, U. Gubler, and A. S. Stem. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874.
7. + T lymphocytes, and NK cells. J. Immunol. 149:3495.
8. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
9. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
10. Yanagida, T., T. Kato, O. Igarashi, T. Inoue, and H. Nariuchi. 1994. Second Signal activity of IL-12 on the proliferation and IL-2R expression of T helper cell-1 clone. J. Immunol. 152:4919.
11. Germann, T., M. K. Gately, D. S. Schoenhaut, M. Lohoff, F. Mattner, S. Fischer, S. C. Jin, E. Schmitt, and E. Rude. 1993. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol. 23:1762.
12. Allavena, P., C. Paganin, D. Zhou, G. Bianchi, S. Sozzani, and A. Mantovani. 1994. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 84:2261.
13. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
14. 2+ independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
15. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873.
16. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
17. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
18. Hanabuchi, S., M. Koyanagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita, and K. Okumura. 1994. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91:4930.
19. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
20. Zou, J. P., N. Yamamoto, T. Fujii, H. Takenaka, M. Kobayashi, S. H. Herrmann, S. F. Wolf, H. Fujiwara, and T. Hamaoka. 1995. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-γ production by anti-tumor T cells. Int. Immunol. 7:1135.